Sichuan Biokin Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sichuan Biokin Pharmaceutical Co., Ltd.

Why is Sichuan Biokin Pharmaceutical Co., Ltd. ?

The company has declared Negative results for the last 4 consecutive quarters

NET SALES(9M) At CNY 2,065.9 MM has Grown at -63.52%
NET PROFIT(9M) At CNY -500.37 MM has Grown at -112.34%
OPERATING CASH FLOW(Y) Lowest at CNY -2,331.46 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 15.04%, its profits have risen by 574%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sichuan Biokin Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Sichuan Biokin Pharmaceutical Co., Ltd.

2.9%

0.40

48.39%

China Shanghai Composite

8.25%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

69.62%

EBIT Growth (5y)

-284.80%

EBIT to Interest (avg)

41.84

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.54

Tax Ratio

35.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1,387.04%

ROE (avg)

42.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

19.21

EV to EBIT

-107.16

EV to EBITDA

-117.07

EV to Capital Employed

21.94

EV to Sales

42.27

PEG Ratio

Dividend Yield

ROCE (Latest)

-20.47%

ROE (Latest)

-24.46%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -107.37% (YoY

NET PROFIT(9M)

Higher at CNY -788.98 MM

NET SALES(Q)

At CNY 94.59 MM has Grown at 40.25%

-25What is not working for the Company

INTEREST(HY)

At CNY 52.73 MM has Grown at 71.85%

DEBT-EQUITY RATIO (HY)

Highest at -10.52 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.31 times

OPERATING PROFIT(Q)

Lowest at CNY -773.67 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -817.95 %

PRE-TAX PROFIT(Q)

Lowest at CNY -846.61 MM

NET PROFIT(Q)

Lowest at CNY -845.02 MM

EPS(Q)

Lowest at CNY -1.88

Here's what is working for Sichuan Biokin Pharmaceutical Co., Ltd.

Net Sales

At CNY 94.59 MM has Grown at 40.25%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost

Fallen by -107.37% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sichuan Biokin Pharmaceutical Co., Ltd.

Interest

At CNY 52.73 MM has Grown at 71.85%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY -846.61 MM has Fallen at -57.12%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -845.02 MM has Fallen at -59.01%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Profit

Lowest at CNY -773.67 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -817.95 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -846.61 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -845.02 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -1.88

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Highest at -10.52 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio